The HSP90 Inhibitor, AT13387, Displays Single Agent Activity in Erlotinib-Sensitive and -Resistant Models of EGFR-Activated NSCLC Keisha Hearn, Tomoko Smyth, Jon Lewis, Vanessa Martins, Neil Thompson, Mohammad Azab, John

First Page		Document Content
Amines Organofluorides Alkynes Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Hsp90 Protein kinase inhibitor Chemistry Organic chemistry Quinazolines		The HSP90 Inhibitor, AT13387, Displays Single Agent Activity in Erlotinib-Sensitive and -Resistant Models of EGFR-Activated NSCLC Keisha Hearn, Tomoko Smyth, Jon Lewis, Vanessa Martins, Neil Thompson, Mohammad Azab, John Add to Reading List Source URL: astx.com Download Document from Source Website File Size: 482,49 KB Share Document on Facebook

	Some people using buy iressa in canada this medication guide. So with that in mind when evaluating the desirability of including a drug of abuse and you won’t need to be bored. Food and Drug Administration. It helps ke DocID: 1r8zb - View Document
	Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016 DocID: 1qPF6 - View Document
	PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using DocID: 1qlMF - View Document
	TECHNOLOGY OFFER A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent DocID: 1pWe8 - View Document
	erlotinib and 3a4 substrate, erlotinib cell lines fda erlotinib supllemental. erlotinib dialogo farmaci. erlotinib egfr erlotinib and gefitinib australia erlotinib lung asians. oral therapy erlotinib rash and erlotinib f DocID: 1pHKm - View Document